Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?-Reference-Cited by-同舟云学术

Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?

Published:2023-07-03 Issue:7 Volume:16 Page:623-630
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Lymperopoulos Anastasios¹

Affiliation:

1. Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL, USA

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2233891

Reference90 articles.

1. FRACTIONATION AND CHARACTERIZATION OF A CYCLIC ADENINE RIBONUCLEOTIDE FORMED BY TISSUE PARTICLES

2. International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases

3. Visualizing Signal Transduction: Receptors, G-Proteins, and Adenylate Cyclases

4. From GTP and G proteins to TRPC channels: a personal account

5. The Glucagon-sensitive Adenyl Cyclase System in Plasma Membranes of Rat Liver

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects;Pharmaceutics;2024-05-22

2. Heart failure management with β-blockers: can we do better?;Current Medical Research and Opinion;2024-04

3. The neurometabolic axis: A novel therapeutic target in heart failure;Life Sciences;2023-11

4. Current Perspective and Mechanistic Insights on Bioactive Plant Secondary Metabolites for the Prevention and Treatment of Cardiovascular Diseases;Cardiovascular & Hematological Disorders-Drug Targets;2023-09